Rivian Automotive (RIVN), the electric vehicle manufacturer, unveiled its fourth-quarter financial results following Wednesday’s market closure, offering crucial insights into its performance.
In Q4, Rivian generated a revenue of $1.32 billion, surpassing the Street’s anticipated $1.26 billion, as per data from Benzinga Pro. However, the company reported a per-share loss of $1.36, missing the expected loss of $1.32 per share.
Throughout the quarter, Rivian achieved significant milestones, producing 17,541 vehicles and delivering 13,972. For the entirety of fiscal year 2023, the company manufactured 57,232 vehicles and delivered 50,122.
CEO RJ Scaringe expressed optimism about Rivian’s progress despite economic challenges, emphasizing their commitment to the automotive industry’s full electrification. However, he acknowledged short-term hurdles stemming from macroeconomic conditions.
Closing the quarter with $9.37 billion in cash reserves and a total liquidity of $10.47 billion, including a revolving credit facility, Rivian is strategically positioned for growth.
Looking ahead to fiscal 2024, Rivian prioritizes cost efficiency and aims to sustain the progress achieved in 2023, particularly in enhancing gross profit per vehicle delivered. Economic and geopolitical uncertainties, especially the impact of historically high interest rates, shape Rivian’s cautious outlook for the year.
The company forecasts producing 57,000 vehicles in 2024, aligning with the previous year’s production figures. However, it anticipates an adjusted EBITDA loss of $2.7 billion for the year.
To bolster cost-effectiveness, Rivian plans to reduce its salaried workforce by approximately 10%. The eagerly awaited unveiling of the Rivian R2 is scheduled for March 7.
Scaringe reiterated Rivian’s commitment to driving cost efficiency, achieving positive margins, and fortifying its go-to-market strategy to support long-term growth.
In response to the report, Rivian shares experienced a 17% decline in after-hours trading, dropping to $12.75, within a 52-week range of $11.68 to $28.06.
